TAMPA, FL - March 09, 2026 - PRESSADVANTAGE - WhiteSands Treatment Center has published a new educational resource ...

Add Yahoo as a preferred source to see more of our stories on Google. A new study has investigated how different medications and therapies compare with placebos in treating ADHD symptoms. Attention ...

New prescriptions for stimulants among adults, largely to treat ADHD, have more than doubled since the start of the COVID-19 ...

A randomized controlled trial (RCT) published in Psychological Medicine demonstrates a significant and clinically relevant reduction in ADHD symptoms in adults using the digital therapy "attexis." ...

Attention-deficit/hyperactivity disorder (ADHD) is a common but complex neurodevelopmental condition characterized by symptoms of inattention, hyperactivity, and ...

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental condition that causes hyperactivity and impulsivity in children and adults. If left untreated ...

In women, ADHD is often overlooked or diagnosed later in adulthood. Psychiatrist Dr. Sasha Hamdani explains the hidden signs ...

Researchers identified three distinct brain “biotypes” of ADHD, each with its own chemical signature—offering new clues about why treatment can feel like trial and error.

Understood reports GLP-1 drugs like Ozempic may improve ADHD symptoms by quieting food thoughts, but more research is needed for direct effects.

A study reveals COVID-19 reshaped stimulant prescribing patterns in Ontario, highlighting increased ADHD diagnoses and concerns over treatment appropriateness.

Medication and behavioral treatments are both widely used to treat ADHD. While medication is often the first-line treatment, patients who receive behavioral treatments—typically therapy, parent ...